Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Shaw

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 21, 2024
The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancerNeil D Wallace, Marliese Alexander, Jing Xie, et al.
Clinical and Translational Radiation Oncology|October 9, 2023
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLCMichael MacManus, Laura Kirby, Benjamin Blyth, et al.
Radiation Oncology (London, England)|September 7, 2019
NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapyNicholas Hardcastle, Michael S Hofman, Ching-Yu Lee, et al.
Wounds : a Compendium of Clinical Research and Practice|July 7, 2017
Wound Care Centers: Critical Thinking and Treatment Strategies for WoundsJean de Leon, Gregory A Bohn, Lawrence DiDomenico, et al.
BJU International|February 12, 2017
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trialShankar Siva, Daniel Pham, Tomas Kron, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2020
Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for OligometastasesPaolo Sogono, Mathias Bressel, Steven David, et al.
Technology in Cancer Research & Treatment|January 11, 2015
Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy PlanningShankar Siva, Thomas Devereux, David L Ball, et al.
Clinical Lung Cancer|March 20, 2025
Completion Rates for Patients Undergoing Concurrent Chemoradiotherapy for Stage III Nonsmall Cell Lung Cancer and its Importance in the Era of Consolidation Immunotherapy: A Cohort StudyNeil D Wallace, Jing Xie, Marliese Alexander, et al.
Radiation Oncology (London, England)|February 14, 2024
Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancerMuhammad Ali, Kendrick Koo, David Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2025
A prospective study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancerNeil D Wallace, Mathias Bressel, Nick Hardcastle, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|March 21, 2024
The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancerNeil D Wallace, Marliese Alexander, Jing Xie, et al.
Clinical and Translational Radiation Oncology|October 9, 2023
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLCMichael MacManus, Laura Kirby, Benjamin Blyth, et al.
Radiation Oncology (London, England)|September 7, 2019
NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapyNicholas Hardcastle, Michael S Hofman, Ching-Yu Lee, et al.
Wounds : a Compendium of Clinical Research and Practice|July 7, 2017
Wound Care Centers: Critical Thinking and Treatment Strategies for WoundsJean de Leon, Gregory A Bohn, Lawrence DiDomenico, et al.
BJU International|February 12, 2017
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trialShankar Siva, Daniel Pham, Tomas Kron, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2020
Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for OligometastasesPaolo Sogono, Mathias Bressel, Steven David, et al.
Technology in Cancer Research & Treatment|January 11, 2015
Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy PlanningShankar Siva, Thomas Devereux, David L Ball, et al.
Clinical Lung Cancer|March 20, 2025
Completion Rates for Patients Undergoing Concurrent Chemoradiotherapy for Stage III Nonsmall Cell Lung Cancer and its Importance in the Era of Consolidation Immunotherapy: A Cohort StudyNeil D Wallace, Jing Xie, Marliese Alexander, et al.
Radiation Oncology (London, England)|February 14, 2024
Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancerMuhammad Ali, Kendrick Koo, David Chang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2025
A prospective study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancerNeil D Wallace, Mathias Bressel, Nick Hardcastle, et al.
Pageof 5